SCHEMBL27362863

SCHEMBL27362863

Cc1ccc(N2CCN(CC3CN(C)C3)CC2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.51
DRD3 P35462 4/20 0.51
DRD1 P21728 3/20 0.51
DRD5 P21918 3/20 0.51
DRD4 P21917 2/20 0.51
HTR1A P08908 1/20 0.51
HTR2A P28223 1/20 0.51
HTR2C P28335 1/20 0.51
SLC6A4 P31645 1/20 0.51
HTR7 P34969 1/20 0.51
DHFR P00374 1/20 0.43
PDE10A Q9Y233 1/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27362867 0.88 DRD2 (0.50) DRD2DRD3DRD1DRD5DRD4
SCHEMBL14853102 0.87 DRD2 (0.51) DRD2DRD3DRD1DRD5DRD4
SCHEMBL27363567 0.85 DRD2 (0.47) DRD2DRD3DRD1DRD5DRD4
SCHEMBL27363705 0.85 DRD2 (0.47) DRD2DRD3DRD1DRD5DRD4
SCHEMBL27364618 0.81 PDE10A (0.42) DRD2DRD3DRD1DRD5DRD4
SCHEMBL27364869 0.81 DHFR (0.39) DRD2HTR1ADHFRGPR119OGA
SCHEMBL27366890 0.81 DRD2 (0.46) DRD2DRD3DRD1DRD5DRD4
SCHEMBL27364505 0.80 PDE10A (0.45) DRD2DRD3DRD1DRD5DRD4
SCHEMBL14853100 0.79 PDE10A (0.48) DRD2DRD3DRD1DRD5DRD4
SCHEMBL153568 0.78 L3MBTL1 (0.57) DRD2DRD3DRD1DRD5DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054591-A1 RAPIDLY ACCELERATED FIBROSARCOMA (RAF) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-03-14 WO disclosed